- Pharma
- May 22, 2025
- 525 views
Bharat Bio successfully completes Phase III trials of new oral cholera vaccine Hillchol
HYDERABAD: Vaccine maker Bharat Biotech on Wednesday said its oral cholera vaccine, Hillchol, successfully completed Phase III clinical trials demonstrating efficacy against both Ogawa and Inaba serotypes. The Hyderabad-based vaccine…